Cite
APA Citation
Rimassa, L., Cheng, A., Braiteh, F., Benzaghou, F., Hazra, S., Borgman, A., Sinha, R., Kayali, Z., Zhu, A., & Kelley, R. (n.d.). p-238Phase 3 (COSMIC-312) study of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100094624941.0x00002f